FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare

Free Newsletter

Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today!

About | Sample | Privacy
Related Topics >> influence | lawsuit | Payments | Medtronic

Lawsuit: Medtronic perks wooed docs

Tools

What do a Memphis gentlemen's club, trips to Alaska and ill-gotten patent royalties have in common? They're all perks that Medtronic gave to doctors, according to a lawsuit brought by a former Medtronic lawyer. The incentives were handed out by the company's $3 billion spinal devices unit, which has already been under investigation for its physician relationships.

As you know, Sen. Charles Grassley has been probing off-label use of Medtronic's spine products, examining whether those unapproved uses were driven by incentives given to doctors. The FDA has warned that off-label use of a Medtronic bone graft has led to potentially life-threatening side effects in dozens of patients.

The allegations were made in a lawsuit, filed in 2002 but only recently--and partially--unsealed. A heavily redacted copy of the complaint is the only version publicly available. But the Wall Street Journal got an unredacted copy, which alleged that kickbacks were "pervasive" in the spinal unit.

Medtronic says that it's changed many business practices since that lawsuit was filed. The company says it's "committed to reform and transparency in the industry."

- read the Wall Street Journal story

Related Articles:
Kickback investigators focus on docs
Feds probe Medtronic payments to docs
Medtronic's doc payments draw new fire
Medtronic will settle accusations on kickbacks (July 2006)

More stories about influence   lawsuit   Payments   Medtronic  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

What is 1 + 12?
To combat spam, please solve the math question above.